Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-α delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas
Stuart A. Grossman, Jane B. Alavi, Jeffrey G. Supko, Kathryn A. Carson, Regina Priet, F. Andrew Dorr, John S. Grundy, Jon T. Holmlund
Dive into the research topics of 'Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-α delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas'. Together they form a unique fingerprint.